Keyphrases
Intravenous Thrombolysis
36%
Ischemic Stroke
33%
Hospitalization
22%
Anticoagulated
22%
Meta-analysis
21%
Cerebrovascular Disease
20%
Heparin
20%
Cerebral Venous Thrombosis
20%
Acute Ischemic Stroke
20%
Acute Stroke
18%
Headache Prophylaxis
18%
Stroke Survivors
18%
Narrative Review
18%
Recombinant Tissue Plasminogen Activator (rt-PA)
18%
COVID-19
18%
Latin American
18%
Intracranial Artery Dissection
18%
Transorbital
18%
Coronavirus Infections
18%
Neurological Manifestations
18%
Stab Injury
18%
Anticoagulant Therapy
18%
Cortical Venous Thrombosis
18%
Pontine
18%
Poor Response
18%
Medullary Strokes
18%
Self-inflicted Injury
18%
United States
18%
In-hospital Stroke
18%
Sexual Dysfunction
18%
Radiological Score
18%
Intracranial Stenosis
18%
Hospital Questionnaires
18%
Stroke Predictors
18%
Arterial Dissection
18%
McDonald Criteria
18%
Clinical Change
18%
Multiple Sclerosis
18%
Patient Management
18%
Acute Management
18%
Systematic Meta-analysis
18%
Repetitive Transcranial Magnetic Stimulation (rTMS)
18%
Comprehensive Stroke Center
18%
Chronic Headache
18%
In-hospital Mortality
15%
Stroke Mortality
15%
Clinical Characteristics
15%
PubMed
13%
Radiological Findings
13%
Etiology
12%
Medicine and Dentistry
Apoplexy
100%
Systematic Review
48%
Brain Ischemia
26%
Cerebrovascular Disease
21%
Multiple Sclerosis
21%
Stab Wound
18%
Vertebral Artery Dissection
18%
Phlebothrombosis
18%
Alteplase
18%
Intracranial Stenosis
18%
Low Drug Dose
18%
Blood Clot Lysis
18%
Drug Megadose
18%
Coronavirus Infection
18%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
COVID-19
18%
Neurologic Finding
18%
Treatment of Multiple Sclerosis
18%
Clinical Trial
14%
Diseases
13%
Neurology
12%
Meta-Analysis
12%
Nervous System
10%
Cerebral Hemorrhage
10%
Clinical Method
9%
Diagnosis of Multiple Sclerosis
9%
Chronic Disease
9%
Central Nervous System
9%
Headache
8%
Respiratory Failure
8%
Coronaviridae
7%
Encephalitis
7%
Contraindication
6%
Drug Abuse
6%
Neurosurgery
6%
Ophthalmology
6%
Posterior Fossa
6%
Pons
6%
Computer Assisted Tomography
6%
Disease
6%
Cohort Analysis
5%
Recurrent Disease
5%
Magnetic Resonance Venography
5%
Anticoagulation
5%
Cohort Effect
5%
Anticoagulant
5%